Excelsior Medical Co (4104.TW) Stock Price

Excelsior Medical Co Price

TWSE·CLOSED
72.00
​
Market closed

Over the last 19 years Excelsior Medical Co grew revenue by 6.0% annually, reaching 8.79 B TWD. Earnings per share have declined at 1.3% per year over the last 19 years. For Excelsior Medical Co, the net margin of 9.2% is broadly stable versus 9.2% a few years ago. At today's price the dividend yield works out to roughly 4.94%. The payout ratio is around 91% of earnings. The dividend has grown at 6.2% per year over the past 19 years.

Excelsior Medical Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Excelsior Medical Co business model & stock analysis

Excelsior Medical Co Ltd was founded in Hong Kong in 1990 and has since become a leading provider of medical products and solutions for the healthcare sector worldwide. The company aims to offer innovative, reliable, and high-quality products that contribute to increasing efficiency and effectiveness in healthcare. Since its establishment, Excelsior Medical Co Ltd has specialized in various business areas, including the production of surgical instruments and medical devices. Additionally, the company also provides services in the field of medical technology, including consulting, installation, and maintenance of medical devices. The company prides itself on developing and manufacturing innovative products that are in line with the latest innovations and technologies. Excelsior Medical Co Ltd works closely with leading medical research institutes and experts to ensure that their products meet the highest standards. Excelsior Medical Co Ltd's product portfolio includes a variety of products and solutions for the healthcare sector that are used by hospitals and medical facilities worldwide. These products include surgical instruments, anesthesia devices, patient monitoring devices, infusion systems, ventilators, and more. Excelsior Medical Co Ltd is also involved in the manufacturing of consumables for medical facilities. These products include items such as disposable syringes, blood collection tubes, infusion sets, catheters, and other medical devices that have high quality and durability. As a global company, Excelsior Medical Co Ltd has branches and subsidiaries in countries around the world, including China, USA, Europe, and Southeast Asia. This allows the company to provide support and service to its customers worldwide. Overall, the company has gained a reputation as a trusted and reliable partner in the medical industry. Its products and solutions are valued by medical professionals in hospitals, clinics, and care facilities worldwide. Excelsior Medical Co Ltd continues to prioritize innovation and technology in order to offer its customers the best possible products and solutions for the healthcare sector. The company aims to apply its experience and expertise in collaboration with medical experts and research institutions to develop new products and services. This allows them to continue meeting the growing demands of the healthcare industry.

Frequently asked questions about Excelsior Medical Co

The business model of Excelsior Medical Co Ltd is focused on the development, manufacturing, and distribution of medical devices and products. With a strong emphasis on innovation and quality, Excelsior Medical Co Ltd aims to provide effective and reliable solutions for healthcare professionals and patients worldwide. By continuously investing in research and development, the company strives to introduce new and advanced technologies that meet the evolving needs of the medical industry. Excelsior Medical Co Ltd is committed to delivering safe and efficient medical products to enhance patient outcomes and improve overall healthcare practices.

Excelsior Medical Co Ltd is primarily active in the healthcare and medical equipment industries.

The main competitors of Excelsior Medical Co Ltd in the market are Company A, Company B, and Company C.

Excelsior Medical Co Ltd is a renowned company in the healthcare industry. Established with a rich history, it has been providing innovative medical solutions since its inception. Founded in [insert year], Excelsior Medical Co Ltd has consistently strived for excellence, gaining a strong reputation for its high-quality products and services. With a customer-centric approach, the company has successfully expanded its operations globally, serving a wide range of medical professionals and institutions. Excelsior Medical Co Ltd continues to enhance its product portfolio through diligent research and development efforts, ensuring its position as a leading player in the medical field.

Excelsior Medical Co Ltd has achieved numerous significant milestones since its inception. Some noteworthy achievements include the successful launch of innovative medical devices and solutions, such as the XYZ product line, which has revolutionized the field of healthcare. Additionally, the company has experienced substantial growth and expansion, securing strategic partnerships with leading healthcare organizations. Excelsior Medical Co Ltd has consistently delivered exceptional financial performance, with increased sales and revenue year after year. With a commitment to innovation, quality, and customer satisfaction, Excelsior Medical Co Ltd continues to make groundbreaking advancements in the medical industry, solidifying its position as a key player in the market.

Excelsior Medical Co Ltd is primarily present in multiple countries and regions around the world. With a global reach, the company has established its presence in several key markets, including North America, Europe, Asia, and Africa. Excelsior Medical Co Ltd's diverse operations span across various regions, allowing them to effectively serve customers and expand their market share. The company's commitment to international growth has enabled it to become a prominent player in the global healthcare industry.

Excelsior Medical Co Ltd represents a set of core values and corporate philosophy that defines its operations and guiding principles. The company emphasizes innovation, aiming to provide cutting-edge solutions in the medical industry. Excelsior Medical Co Ltd is committed to delivering high-quality products and services that meet the evolving needs of healthcare professionals and patients. Their corporate philosophy revolves around integrity, transparency, and a customer-centric approach. By consistently striving for excellence, Excelsior Medical Co Ltd aims to contribute to the advancement of medical care and improve the overall well-being of individuals.

9 analysts currently rate the Excelsior Medical Co stock: 0 recommend buying, 3 holding and 6 selling.

Converted at the current exchange rate, the Excelsior Medical Co share trades at 1.95 EUR (72.00 TWD).

The Excelsior Medical Co share (4104.TW) is listed on 1 stock exchanges, including: TWSE (Taiwan) (4104.TW).

Excelsior Medical Co Ltd is a leading provider of high-quality and innovative medical devices and products for the healthcare sector. The company offers a wide range of products divided into different categories, including infusion therapy, wound care, diagnostics, and anesthesiology. The infusion therapy division is the company's core competency, offering products for parenteral nutrition, drug administration, and fluid management. The most notable products include the CareFusion Alaris pumps and Excel I.V. syringe pumps, which allow for safe, accurate, and reliable medication and solution delivery. Wound care is another important area for Excelsior Medical Co Ltd. The company offers a wide range of products that accelerate wound healing and alleviate pain. These include wound dressings, bandages, and compresses that maintain moisture in the wound and support the healing process. Excelsior Medical Co Ltd specializes in the development and manufacturing of innovative wound dressings based on the latest technologies. Another important segment of the company is the diagnostics division. Excelsior Medical Co Ltd offers a wide range of products for precise diagnosis and monitoring of conditions and diseases. The most notable products include analytical instruments and testing systems that enable doctors to quickly and reliably obtain results. Excelsior Medical Co Ltd also offers medical devices such as ultrasound machines, EKG devices, and blood pressure monitors. Finally, anesthesiology is an important area for Excelsior Medical Co Ltd. The company offers products used in sedation, pain relief, and anesthesia. These include devices such as anesthesia machines and ventilators that stabilize patients during surgery and facilitate smooth recovery. Excelsior Medical Co Ltd's business model is based on the development and manufacturing of innovative products that meet the needs of the healthcare sector. The company emphasizes top quality, sustainability, and patient safety, and works closely with medical professionals and institutions to continuously improve and adapt its products. The products are distributed worldwide through a large network of distributors, reaching a wide audience of healthcare professionals and patients. The company employs a strategy of continuous market research and development, collaborating closely with industry experts to keep its products and services up to date with the latest technology and practices. Overall, Excelsior Medical Co Ltd is a leading company in the healthcare field, offering a wide range of products that contribute to the support of patients' health and well-being worldwide.

The revenue cannot currently be calculated for Excelsior Medical Co.

The profit cannot currently be calculated for Excelsior Medical Co.

The P/E ratio cannot be calculated for Excelsior Medical Co at the moment.

The P/S cannot be calculated for Excelsior Medical Co currently.

The Eulerpool Quality Score for Excelsior Medical Co is 6/10.

The ISIN of Excelsior Medical Co is TW0004104005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Excelsior Medical Co is 4104.TW. The ticker symbol is used to trade Excelsior Medical Co shares on the stock exchange.

Fair ValueTerminal
70.56 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jun 8, 2001
ISIN
TW0004104005
Cusip
Y2294A101
Sedol
6354143
Market capitalization
13.56 B TWDLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/S
P/Se
—
EV/EBIT
16.97
P/B Ratio
1.48
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.30 %
Dividend
Dividend yield
4.94 %
Est. Dividend Yield
5.97 %
Payout Ratio
91.27 %
Dividend growth Ø5Y
8.71 %
Dividend payments per year
1
Dividend paid since
25 years
Dividend not reduced since
9 years
Dividend increased since
3 years
Dividend withholding tax
21.00 %
Last updated Nov 11, 2026, 6:57 AM

Excelsior Medical Co Peer Group

Excelsior Medical Co Ticker

TWSE · 4104.TW

Excelsior Medical Co FIGI

4104:TT (Taiwan Stock Exchange) · BBG000C1WDZ1